IL-6 induces expression of the Fli-1 proto-oncogene via STAT3

被引:31
作者
Hodge, DR
Li, DP
Qi, SM
Farrar, WL
机构
[1] NCI, Frederick Canc Res & Dev Ctr, Mol Immunoregulat Lab, Frederick, MD 21702 USA
[2] NCI, Frederick Canc Res & Dev Ctr, SAIC Frederick, Intramural Res Support Program, Frederick, MD 21702 USA
[3] NCI, Frederick Canc Res & Dev Ctr, Cytokine Mol Mech Sect, Frederick, MD 21702 USA
[4] Aphton Corp, Mol Med Lab, Miami, FL 33130 USA
关键词
D O I
10.1006/bbrc.2002.6652
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Induction of gene expression by IL-6 has become an area of intense interest due to the role this cytokine plays in mediating aspects of inflammation, cellular differentiation, and proliferation. The ETS family of transcription factors represents a group of positive and negative regulators of transcription, that are differentially expressed in a cell and tissue specific manner. The ETS protein Fli-I is known to induce differentiation in the erythroblastic leukemia cell line K562 along megakaryocytic developmental pathways. Here we show that IL-6 treatment of K562 induces the expression of Fli-1 via the STAT3 transcription factor. Upregulation of Fli-1 expression can be abrogated by the addition of AG490, a chemical inhibitor of JAK kinases, and by transfecting the cells with a dominant negative STAT3 expression construct.
引用
收藏
页码:287 / 291
页数:5
相关论文
共 27 条
[1]   FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells [J].
Athanasiou, M ;
Mavrothalassitis, G ;
Sun-Hoffman, L ;
Blair, DG .
LEUKEMIA, 2000, 14 (03) :439-445
[2]  
Athanasiou M, 1996, CELL GROWTH DIFFER, V7, P1525
[3]   Presence of new alternative exons in human and mouse Fli-1 genes [J].
Barat, C ;
Barbeau, B ;
Delattre, O ;
Rassart, E .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2000, 1517 (01) :164-170
[4]   The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1 [J].
Barbeau, B ;
Barat, C ;
Bergeron, D ;
Rassart, E .
ONCOGENE, 1999, 18 (40) :5535-5545
[5]   Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenic Ets transcription factor Fli-1 [J].
Bastian, LS ;
Kwiatkowski, BA ;
Breininger, J ;
Danner, S ;
Roth, G .
BLOOD, 1999, 93 (08) :2637-2644
[6]   IDENTIFICATION AND MAPPING OF A COMMON PROVIRAL INTEGRATION SITE FLI-1 IN ERYTHROLEUKEMIA-CELLS INDUCED BY FRIEND MURINE LEUKEMIA-VIRUS [J].
BENDAVID, Y ;
GIDDENS, EB ;
BERNSTEIN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1332-1336
[7]   Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma [J].
Dankbar, B ;
Padró, T ;
Leo, R ;
Feldmann, B ;
Kropff, M ;
Mesters, RM ;
Serve, H ;
Berdel, WE ;
Kienast, J .
BLOOD, 2000, 95 (08) :2630-2636
[8]   Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes [J].
Deveaux, S ;
Filipe, A ;
Lemarchandel, V ;
Ghysdael, J ;
Romeo, PH ;
Mignotte, V .
BLOOD, 1996, 87 (11) :4678-4685
[9]   Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics [J].
Folpe, AL ;
Chand, EM ;
Goldblum, JR ;
Weiss, SW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (08) :1061-1066
[10]   Expression of urokinase plasminogen activator and receptor in conjunction with the ets family and AP-1 complex transcription factors in high grade prostate cancers [J].
Gavrilov, D ;
Kenzior, O ;
Evans, M ;
Calaluce, R ;
Folk, WR .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (08) :1033-1040